Smith & Nephew plc

NYSE:SNN

Medical - Devices

Healthcare
$30.32 -1.39%

-$0.43 today

Market cap
$12.72B
Beta
0.67
P/E (TTM)
20.1
EPS (TTM)
$0.74
Dividend yield
2.59%
52W Low $28.79High $38.79

Volume 1.22M

Average 1.10M

SNN Accumulated OCI

Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.

Smith & Nephew plcNYSE: SNN

Accumulated OCI · Q4 FY2025 · quarter ended Dec 2025

Accumulated OCI remains negative

Q4 FY2025 Accumulated OCI was $20M, compared with $0 a year earlier.

Context

  • Accumulated OCI amounted to 0.2% of total assets at the end of Q4 FY2025, up 0.2 pp from a year earlier.
  • Accumulated OCI increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterDec 2025
$20M— QoQ
Last fiscal yearDec 2025
$20M— YoY
Year agoDec 2024
$0— since
Accumulated OCI past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accumulated OCI history

USD · from the balance sheet

Latest · FY2025
20M USD
Year-over-year change
—

Accumulated OCI vs competitors

How SNN compares with its peers on the latest reported figures

  • SNN's Dec 2025 Accumulated OCI of $20M is the highest of the 11 companies compared; the peer median is -$18.69M.
  • Accumulated OCI amounts to 0.2% of total assets for SNN, versus a peer median of 0.8%.
SNN Competitors Peer median
Accumulated OCI for SNN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SNNSmith & Nephew plcDec 2025$20M ——0.2%
GMEDGlobus Medical, Inc.Jun 2026$11.2M +9.3%—0.2%
OFIXOrthofix Medical Inc.Mar 2026$142K +105.6%—0.0%
XTNTXtant Medical Holdings, Inc.Mar 2026-$1K +99.5%—0.0%
KIDSOrthoPediatrics Corp.Mar 2026-$1.4M +87.9%—0.3%
ATECAlphatec Holdings, Inc.Mar 2026-$6.45M +38.4%—0.8%
IARTIntegra LifeSciences Holdings CorporationMar 2026-$30.94M -28.3%—0.9%
CNMDCONMED CorporationMar 2026-$44.69M +22.1%—1.9%
ENOVEnovis CorporationApr 2026-$103.76M -59.7%—2.7%
ZBHZimmer Biomet Holdings, Inc.Jun 2026-$163.9M +42.4%—0.7%
SYKStryker CorporationJun 2026-$576M +24.4%—1.2%
Peer median (excluding SNN) -$18.69M+31.4%—0.8%

Competitors are the stored peer set for SNN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents1.29B350M302M619M557M
Short-term Investments00000
Net Receivables971M1.03B1.06B1.21B1.43B
Inventory1.84B2.21B2.4B2.39B2.12B
Other Current Assets240M198M182M81M(99M)
Total Current Assets4.42B3.86B4.03B4.42B4.1B
Property, Plant & Equipment (Net)1.51B1.46B1.47B1.42B1.64B
Goodwill2.99B3.03B2.99B3.03B3.11B
Intangible Assets1.4B1.24B1.11B1.03B882M
Long-term Investments380M58M24M16M151M
Tax Assets201M177M274M334M347M
Other Non-current Assets15M153M87M103M228M
Total Non-current Assets6.5B6.11B5.96B5.93B6.35B
Total Assets10.92B9.97B9.99B10.35B10.46B
Account Payables1.04B1.03B1.02B1.08B1.16B
Short-term Debt435M111M710M2M83M
Tax Payables222M214M218M232M0
Deferred Revenue00000
Other Current Liabilities597M526M261M126M85M
Total Current Liabilities2.13B1.72B2.27B1.53B1.6B
Long-term Debt2.71B2.57B2.18B3.12B3.03B
Deferred Tax Liabilities144M36M9M31M40M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities229M244M171M269M356M
Total Non-current Liabilities3.22B2.99B2.5B3.56B3.57B
Total Liabilities5.35B4.71B4.77B5.09B5.17B
Common Stock177M175M175M175M175M
Retained Earnings5.23B5.03B4.91B5.02B5.32B
Accumulated OCI(328M)(439M)(385M)020M
Other Stockholders Equity000(497M)(329M)
Minority Interest00000
Total Equity5.57B5.26B5.22B5.27B5.29B
Total Debt3.34B2.87B3.08B3.32B3.33B
Net Debt2.05B2.52B2.78B2.7B2.77B

Smith & Nephew plc

NYSE:SNN

Intrinsic Alpha fair value

Locked

Current Price

$30.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.